Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Leary

Showing results (11-20 of 217) with videos related to

Pageof 22
Sort By:
Cancer Investigation|July 31, 2007
Small molecule signal transduction inhibitors for the treatment of solid tumorsAlexandra Leary, Stephen R D Johnston
Therapeutic Advances in Medical Oncology|August 23, 2021
Immune checkpoint inhibitors in ovarian cancer: where do we stand?Alexandra Leary, David Tan, Jonathan Ledermann
The Breast Journal|August 4, 2009
Ipsilateral breast tumor recurrence: is there any evidence for benefit of further systemic therapy?Bhawna Sirohi, Alexandra Leary, Stephen R D Johnston
Bulletin Du Cancer|February 4, 2018
[Erratum to: "Histological and molecular classification of endometrial carcinoma and therapeutical implications" [Bull. Cancer 104 (2017) 1001-1012]]Catherine Genestie, Alexandra Leary, Mojgan Devouassoux, et al.
Expert Review of Anticancer Therapy|April 13, 2019
Rucaparib in the landscape of PARP inhibition in ovarian cancerEmeline Colomba, Patricia Pautier, Fanny Pommeret, et al.
Bulletin Du Cancer|October 17, 2017
[Histological and molecular classification of endometrial carcinoma and therapeutical implications]Catherine Genestie, Alexandra Leary, Mojgan Devouassoux, et al.
International Journal of Cancer|December 9, 2017
Impact of neoadjuvant chemotherapy on the immune microenvironment in advanced epithelial ovarian cancer: Prognostic and therapeutic implicationsAya S Khairallah, Catherine Genestie, Aurélie Auguste, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|October 12, 2017
Ovarian Cancer: A Heterogeneous DiseaseMyriam Kossaï, Alexandra Leary, Jean-Yves Scoazec, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Primary Surgery or Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: The Debate Continues…Alexandra Leary, Renee Cowan, Dennis Chi, et al.
Lancet (London, England)|September 11, 2015
Endometrial cancerPhilippe Morice, Alexandra Leary, Carien Creutzberg, et al.
Pageof 22

Showing results (11-20 of 217) with videos related to

Sort By:
Pageof 22
Cancer Investigation|July 31, 2007
Small molecule signal transduction inhibitors for the treatment of solid tumorsAlexandra Leary, Stephen R D Johnston
Therapeutic Advances in Medical Oncology|August 23, 2021
Immune checkpoint inhibitors in ovarian cancer: where do we stand?Alexandra Leary, David Tan, Jonathan Ledermann
The Breast Journal|August 4, 2009
Ipsilateral breast tumor recurrence: is there any evidence for benefit of further systemic therapy?Bhawna Sirohi, Alexandra Leary, Stephen R D Johnston
Bulletin Du Cancer|February 4, 2018
[Erratum to: "Histological and molecular classification of endometrial carcinoma and therapeutical implications" [Bull. Cancer 104 (2017) 1001-1012]]Catherine Genestie, Alexandra Leary, Mojgan Devouassoux, et al.
Expert Review of Anticancer Therapy|April 13, 2019
Rucaparib in the landscape of PARP inhibition in ovarian cancerEmeline Colomba, Patricia Pautier, Fanny Pommeret, et al.
Bulletin Du Cancer|October 17, 2017
[Histological and molecular classification of endometrial carcinoma and therapeutical implications]Catherine Genestie, Alexandra Leary, Mojgan Devouassoux, et al.
International Journal of Cancer|December 9, 2017
Impact of neoadjuvant chemotherapy on the immune microenvironment in advanced epithelial ovarian cancer: Prognostic and therapeutic implicationsAya S Khairallah, Catherine Genestie, Aurélie Auguste, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|October 12, 2017
Ovarian Cancer: A Heterogeneous DiseaseMyriam Kossaï, Alexandra Leary, Jean-Yves Scoazec, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Primary Surgery or Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: The Debate Continues…Alexandra Leary, Renee Cowan, Dennis Chi, et al.
Lancet (London, England)|September 11, 2015
Endometrial cancerPhilippe Morice, Alexandra Leary, Carien Creutzberg, et al.
Pageof 22